Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.30 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6676603 | 0.98 | TDP1 (0.36) | TDP1CYP4F2CYP4A11 | |
| SCHEMBL29000774 | 0.98 | TDP1 (0.36) | TDP1CYP4F2CYP4A11 | |
| SCHEMBL1467658 | 0.94 | TDP1 (0.31) | TDP1 | |
| SCHEMBL5156789 | 0.86 | — | — | |
| SCHEMBL7704514 | 0.81 | CHRM2 (0.35) | — | |
| SCHEMBL6209232 | 0.80 | ADH1C (0.36) | — | |
| SCHEMBL7386766 | 0.79 | ADH1C (0.30) | — | |
| SCHEMBL7391165 | 0.79 | ADH1C (0.30) | — | |
| SCHEMBL989108 | 0.79 | CHRM2 (0.39) | — | |
| SCHEMBL9866159 | 0.79 | TSHR (0.40) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115353770-B | Gel pen ink with optimized writing performance | 南京一墨纳米技术有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-115353770-A | Gel pen ink with optimized writing performance | 南京一墨纳米技术有限公司 | 2022-11-18 | — | — | CN | claimed |
| CN-114437585-A | Writing pen ink for files and preparation method thereof | 鼎纳科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-118206559-A | PROTAC chimeric compounds, preparation method and use thereof | 杭州中美华东制药有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-117777187-A | Triphenyl phosphate hapten as well as preparation method and application thereof | 北京维德维康生物技术有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117305301-A | Oligonucleotide for inhibiting ASGPR-1 gene or pharmaceutically acceptable salt thereof and application | 弘亮(上海)生物医药科技有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-116120390-B | Tripterine derivative and preparation method and application thereof | 中国药科大学 | 2023-12-22 | — | — | CN | disclosed |
| CN-117003744-A | Five-membered and six-membered compound, intermediate, preparation method, composition and application | 厦门市博瑞来医药科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116903684-A | Liver targeting compound and oligonucleotide conjugate and application thereof | 弘亮(上海)生物医药科技有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116732034-A | Oligonucleotide for inhibiting AGT gene or pharmaceutically acceptable salt thereof and application | 弘亮(上海)生物医药科技有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-116406272-A | DNA-PK selective inhibitor and preparation method and application thereof | 首药控股(北京)股份有限公司 | 2023-07-07 | — | — | CN | disclosed |
| CN-116120390-A | Tripterine derivative and preparation method and application thereof | 中国药科大学 | 2023-05-16 | — | — | CN | disclosed |
| CN-115353770-A | Gel pen ink with optimized writing performance | 南京一墨纳米技术有限公司 | 2022-11-18 | — | — | CN | disclosed |
| US-7365174-B2 | Azalide and azalactam derivatives and method for producing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| US-20070042974-A1 | Nozel azalide and azalactam derivatives and method for producing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2007-02-22 | — | — | US | disclosed |
| EP-1661904-A1 | NOVEL AZALIDE AND AZALACTAM DERIVATIVES AND PROCESS FOR THE PRODUCTION OF THE SAME | MEIJI SEIKA KAISHA LTD. (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-0779281-B1 | ISOXAZOLES | SANKYO CO (JP) | 2003-10-29 | — | — | EP | disclosed |
| US-6096771-A | ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE | SANKYO COMPANY, LIMITED (JP) | 2000-08-01 | — | — | US | disclosed |
| US-5965591-A | MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE | SANKYO COMPANY, LIMITED (JP) | 1999-10-12 | — | — | US | disclosed |
| EP-0779281-A1 | ISOXAZOLES | SANKYO COMPANY LIMITED (JP) | 1997-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042974-A1 | Nozel azalide and azalactam derivatives and method for producing the same | BCL6, NR4A1, NR4A2 | TDP1 4481/4885CYP4F2 796/4885CYP4A11 221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.